JANSSENMED, created in 2013 (United States), from 2466 sister brands and 17477 competing brands. The JANSSENMED brand is owned by JOHNSON & JOHNSON, a company listed in New York. JANSSENMED is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(JANSSENMED)
over 5 years*
USD 147.49